Cleerly, a leader in AI imaging technology, is proud to support the American College of Cardiology's (ACC) Chicago Community Health Fair. This event will take place on Tuesday, March 25, from 3-7 p.m.

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

Heart disease remains one of the leading causes of death in the United States, but with the right knowledge and proactive care, patients can improve both their quality of life and longevity.

Explore how emotions impact heart health and discover practical ways to manage stress, depression, and anger for a healthier ...

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain.

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

New Precision Medicine Approach Helps Detect Subgroups of People With Obesity at High Risk of Diabetes and Heart Disease Oct. 24, 2024 — Obesity is a common cause of diabetes, heart disease and ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...